ANVISA Adopts Certara’s Phoenix Software for Drug Regulatory Reviews


Applied Clinical Trials

Certara announced that the Brazilian National Health Surveillance Agency, ANVISA is now also employing Certara’s Phoenix WinNonlin software for reviewing drug regulatory submissions. With the adoption of Certara's software, reviewed studies will be evauated to see if they follow good bioequivalence practices.

Read the full release here

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.